Performant Financial Corporation (PFMT) Business Metric Overview - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Performant Financial Corp...

    NASDAQ: PFMT · Real-Time Price · USD
    3.56
    -0.12 (-3.26%)
    At close: Dec 17, 2024, 10:00 PM

    Performant Financial Revenue Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
    Claims-Based Revenue 19.71M 17.1M 62.2M 14.22M 25.8M 31.13M 28.49M 23.93M 22.89M 26.03M 23.52M 21.76M 23.36M 25.56M 20.01M 18.6M 13.29M 18.87M 17.57M 14.59M 17.52M 14.29M 10.76M 9.26M 10.17M 7.47M 6.09M 31.31M
    Claims-Based Revenue Growth +15.24% -72.50% +337.53% -44.90% -17.13% +9.28% +19.06% +4.53% -12.05% +10.66% +8.10% -6.88% -8.59% +27.75% +7.55% +40.01% -29.58% +7.40% +20.37% -16.73% +22.65% +32.83% +16.13% -8.95% +36.09% +22.64% -80.54% n/a
    Eligibility-Based Revenue 18.09M 16.08M n/a 16.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Eligibility-Based Revenue Growth +12.50% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Health Care Revenue 37.8M 33.19M n/a 30.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Health Care Revenue Growth +13.91% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Operating Expense Breakdown

    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue n/a n/a 73.72M 25.97M 24.53M 23.22M 23.31M 22.98M 21.71M 22.45M 22.21M 21.76M 20.9M 20.44M 20.37M 19.69M 23.3M 24.09M 26.16M 23.52M 22.17M 28.8M 28.38M 28.77M 28.93M 29.12M 27.78M 24.28M 22.3M 21.78M 20.55M 20.49M 20.45M 20.7M 18.76M 18.71M 20.06M 21.34M 20.48M 21.73M 22.14M 23.72M
    Selling, General, and Administrative Revenue Growth n/a -100.00% +183.91% +5.84% +5.65% -0.37% +1.43% +5.85% -3.29% +1.07% +2.08% +4.10% +2.27% +0.34% +3.47% -15.49% -3.30% -7.92% +11.22% +6.12% -23.05% +1.50% -1.37% -0.55% -0.64% +4.80% +14.44% +8.84% +2.41% +5.99% +0.28% +0.22% -1.19% +10.34% +0.25% -6.73% -5.98% +4.17% -5.74% -1.87% -6.67% n/a
    Research and Development Revenue n/a n/a n/a n/a n/a n/a 4.3M n/a n/a n/a 3.4M n/a n/a n/a 3M n/a n/a n/a 3.1M n/a n/a n/a 5.8M n/a n/a n/a 6.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research and Development Revenue Growth n/a n/a n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist